⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8967157 | 1.00 | — | — | |
| SCHEMBL1289462 | 0.81 | — | — | |
| SCHEMBL11561058 | 0.78 | — | — | |
| SCHEMBL1896988 | 0.78 | — | — | |
| Ammonia Solution, Strong SCHEMBL11564799 | 0.78 | — | — | |
| SCHEMBL11559583 | 0.78 | — | — | |
| SCHEMBL503541 | 0.78 | — | — | |
| SCHEMBL9113487 | 0.78 | — | — | |
| Phosphine SCHEMBL21676318 | 0.78 | — | — | |
| SCHEMBL27405083 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1100194-A | — | — | None | — | — | JP | disclosed |
| EP-0294196-B1 | Chemical capping by phosphitylation during oligonucleotide synthesis | LYNX THERAPEUTICS INC (US) | 1996-03-06 | — | — | EP | disclosed |
| JP-H01100194-A | CHEMICAL CAPPING BY PHOSPHITYLATION DURING OLIGONUCLEOTIDE SYNTHESIS | APPLIED BIOSYSTEMS INC | 1989-04-18 | — | — | JP | disclosed |
| US-4816571-A | Chemical capping by phosphitylation during oligonucleotide synthesis | APPLIED BIOSYSTEMS, INC. (US) | 1989-03-28 | — | — | US | disclosed |
| EP-0294196-A2 | Chemical capping by phosphitylation during oligonucleotide synthesis | LYNX THERAPEUTICS, INC. (US) | 1988-12-07 | — | — | EP | disclosed |